EU in disarray: what's happening to the single market?
This article was originally published in Clinica
Executive Summary
Last week's ruling by the EU's highest court that a product can be a medical device in one member state and a medicinal product in another qualifies as one of the most disruptive to date. It also comes at an interesting time, as other developments challenge the very principle of the EU single market.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.